Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Deep Convolutional Neural Network-aided Detection of Portal Hypertension in Patients With Cirrhosis.

Liu Y, Ning Z, Örmeci N, An W, Yu Q, Han K, Huang Y, Liu D, Liu F, Li Z, Ding H, Luo H, Zuo C, Liu C, Wang J, Zhang C, Ji J, Wang W, Wang Z, Wang W, Yuan M, Li L, Zhao Z, Wang G, Li M, Liu Q, Lei J, Liu C, Tang T, Akçalar S, Çelebioğlu E, Üstüner E, Bilgiç S, Ellik Z, Asiller ÖÖ, Liu Z, Teng G, Chen Y, Hou J, Li X, He X, Dong J, Tian J, Liang P, Ju S, Zhang Y, Qi X.

Clin Gastroenterol Hepatol. 2020 Mar 20. pii: S1542-3565(20)30346-3. doi: 10.1016/j.cgh.2020.03.034. [Epub ahead of print]

PMID:
32205218
2.

Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.

Weng Q, Chen M, Yang W, Li J, Fan K, Xu M, Weng W, Lv X, Fang S, Zheng L, Song J, Zhao Z, Fan X, Ji J.

FASEB J. 2020 Feb 20. doi: 10.1096/fj.201902895R. [Epub ahead of print]

PMID:
32080912
3.

Iron and oxidizing species in oxidative stress and Alzheimer's disease.

Zhao Z.

Aging Med (Milton). 2019 Jun 20;2(2):82-87. doi: 10.1002/agm2.12074. eCollection 2019 Jun. Review.

4.

Delivery strategies of cancer immunotherapy: recent advances and future perspectives.

Zhao Z, Zheng L, Chen W, Weng W, Song J, Ji J.

J Hematol Oncol. 2019 Nov 28;12(1):126. doi: 10.1186/s13045-019-0817-3. Review.

5.

A Novel Predictor Tool of Biochemical Recurrence after Radical Prostatectomy Based on a Five-MicroRNA Tissue Signature.

Zhao Z, Weickmann S, Jung M, Lein M, Kilic E, Stephan C, Erbersdobler A, Fendler A, Jung K.

Cancers (Basel). 2019 Oct 21;11(10). pii: E1603. doi: 10.3390/cancers11101603.

6.

Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.

Zhang Y, Song J, Zhao Z, Yang M, Chen M, Liu C, Ji J, Zhu D.

Cancer Lett. 2020 Feb 1;470:84-94. doi: 10.1016/j.canlet.2019.10.016. Epub 2019 Oct 11.

PMID:
31610266
7.

LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1.

Tu J, Zhao Z, Xu M, Chen M, Weng Q, Ji J.

Biomed Pharmacother. 2019 Oct;118:109213. doi: 10.1016/j.biopha.2019.109213. Epub 2019 Jul 31.

8.

Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT.

Fan X, Song J, Zhao Z, Chen M, Tu J, Lu C, Wu F, Zhang D, Weng Q, Zheng L, Xu M, Ji J.

Cancer Lett. 2019 Sep 28;460:119-127. doi: 10.1016/j.canlet.2019.06.008. Epub 2019 Jun 14.

PMID:
31207322
9.

Short-term efficacy, safety, and cost-effectiveness of transarterial chemoembolization with drug-eluting beads versus synchronous radiochemotherapy for cervical cancer.

Song J, Chen W, Zhu X, Zhao Z, Chen M, Huang L, Tu J, Zhou H, Zhou L, Ji J.

Int J Gynaecol Obstet. 2019 Oct;147(1):29-35. doi: 10.1002/ijgo.12888. Epub 2019 Aug 18.

PMID:
31206641
10.

Value of TSCT Features for Differentiating Preinvasive and Minimally Invasive Adenocarcinoma From Invasive Adenocarcinoma Presenting as Subsolid Nodules Smaller Than 3 cm.

Wang H, Weng Q, Hui J, Fang S, Wu X, Mao W, Chen M, Zheng L, Wang Z, Zhao Z, Zhou L, Tu J, Xu M, Huang Y, Ji J.

Acad Radiol. 2020 Mar;27(3):395-403. doi: 10.1016/j.acra.2019.05.005. Epub 2019 Jun 11.

11.

Recognition of Lung Adenocarcinoma-specific Gene Pairs Based on Genetic Algorithm and Establishment of a Deep Learning Prediction Model.

Zhao Z, Fan X, Yang L, Song J, Fang S, Tu J, Chen M, Li J, Zheng L, Wu F, Zhang D, Ying X, Ji J.

Comb Chem High Throughput Screen. 2019;22(4):256-265. doi: 10.2174/1386207322666190530102245.

PMID:
31142257
12.

Detection and identification of the oxidizing species generated from the physiologically important Fenton-like reaction of iron(II)-citrate with hydrogen peroxide.

Zeng B, Zhang P, Zheng M, Xiao N, Han J, Wang C, Wang Z, Zhao Z.

Arch Biochem Biophys. 2019 Jun 15;668:39-45. doi: 10.1016/j.abb.2019.05.006. Epub 2019 May 14.

PMID:
31100219
13.

Changes in hepatic metabolic profile during the evolution of STZ-induced diabetic rats via an 1H NMR-based metabonomic investigation.

Chen M, Zheng H, Xu M, Zhao L, Zhang Q, Song J, Zhao Z, Lu S, Weng Q, Wu X, Yang W, Fan X, Gao H, Ji J.

Biosci Rep. 2019 Apr 23;39(4). pii: BSR20181379. doi: 10.1042/BSR20181379. Print 2019 Apr 30.

14.

Nature of Monomeric Molybdenum(VI) Cations in Acid Solutions Using Theoretical Calculations and Raman Spectroscopy.

Zhang N, Königsberger E, Duan S, Lin K, Yi H, Zeng D, Zhao Z, Hefter G.

J Phys Chem B. 2019 Apr 18;123(15):3304-3311. doi: 10.1021/acs.jpcb.9b00926. Epub 2019 Apr 9.

PMID:
30913876
15.

Primary Clinical Application of Y-Shaped Jogged Stent Implantation in Patients with Malignant Hilar Biliary Obstruction.

Zhao Z, Song J, Fan X, Fang S, Chen M, Chen W, Wu F, Zheng L, Tu J, Ji J.

J Gastrointest Surg. 2019 Apr;23(4):745-750. doi: 10.1007/s11605-019-04131-1. Epub 2019 Feb 21.

PMID:
30790219
16.

Parameter-efficient bioclogging model: calibration and comparison with laboratory data.

Hua G, Shao C, Cheng Y, Kong J, Zhao Z.

Environ Sci Pollut Res Int. 2019 Feb;26(4):3731-3740. doi: 10.1007/s11356-018-3894-x. Epub 2018 Dec 11.

PMID:
30539400
17.

LINC00707 contributes to hepatocellular carcinoma progression via sponging miR-206 to increase CDK14.

Tu J, Zhao Z, Xu M, Chen M, Weng Q, Wang J, Ji J.

J Cell Physiol. 2019 Jul;234(7):10615-10624. doi: 10.1002/jcp.27737. Epub 2018 Nov 29.

PMID:
30488589
18.

Anodic passivation on the recycling of cemented carbide scrap by selective electro-dissolution.

Sun F, Chen X, Zhao Z.

Waste Manag. 2018 Oct;80:285-291. doi: 10.1016/j.wasman.2018.09.014. Epub 2018 Sep 21.

PMID:
30455009
19.

CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance.

Xu M, Fang S, Song J, Chen M, Zhang Q, Weng Q, Fan X, Chen W, Wu X, Wu F, Tu J, Zhao Z, Ji J.

Cell Death Dis. 2018 Sep 20;9(10):957. doi: 10.1038/s41419-018-0974-2.

20.

miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma.

Ralla B, Busch J, Flörcken A, Westermann J, Zhao Z, Kilic E, Weickmann S, Jung M, Fendler A, Jung K.

Cancers (Basel). 2018 Sep 10;10(9). pii: E321. doi: 10.3390/cancers10090321.

Supplemental Content

Loading ...
Support Center